Precision Cardiovascular Component Supply

The contract pertains to the supply of high-precision bioprosthetic valves, stent frames, and delivery catheters essential for the assembly of transcatheter aortic valve replacement devices. These components are critical medical devices used in minimally invasive cardiac procedures and must meet rigorous clinical and manufacturing standards to ensure patient safety and procedural efficacy. The subcontractor is expected to deliver these components in accordance with strict quality control protocols, likely including compliance with FDA regulations and ISO standards, though specific performance metrics or volume requirements are not detailed. The contract was posted on May 15, 2026, under the NAICS code 339112, indicating classification within medical device manufacturing. It is administered by the Department of Veterans Affairs through the Network Contract Office 23, suggesting the components will support VA healthcare operations. While the place of performance and point of contact are unspecified, the contract falls under a federal subcontracting framework and is accessible through the SAM.gov portal for transparency and sourcing purposes. No set-aside provisions or small business preferences are indicated, and the nature of the agreement implies ongoing, reliable supply chain functionality for a high-stakes medical application.